Zandra E Walton, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2024 | 271 | 0.690 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2024 | 302 | 0.680 |
Why?
|
| Giant Cell Arteritis | 1 | 2024 | 307 | 0.670 |
Why?
|
| Circadian Clocks | 2 | 2019 | 168 | 0.650 |
Why?
|
| Cell Hypoxia | 2 | 2019 | 662 | 0.640 |
Why?
|
| Lysosomes | 2 | 2019 | 938 | 0.540 |
Why?
|
| Proto-Oncogene Proteins c-myc | 5 | 2023 | 998 | 0.470 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2024 | 1512 | 0.450 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2019 | 2062 | 0.370 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2010 | 64 | 0.340 |
Why?
|
| CLOCK Proteins | 2 | 2018 | 87 | 0.270 |
Why?
|
| Protein Engineering | 1 | 2010 | 553 | 0.270 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2019 | 2486 | 0.220 |
Why?
|
| Enzyme Inhibitors | 2 | 2010 | 3728 | 0.180 |
Why?
|
| ras Proteins | 4 | 2014 | 1058 | 0.170 |
Why?
|
| Telomere | 2 | 2018 | 944 | 0.170 |
Why?
|
| Phosphoproteins | 3 | 2018 | 2451 | 0.160 |
Why?
|
| Amino Acids, Dicarboxylic | 1 | 2018 | 23 | 0.160 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2018 | 83 | 0.150 |
Why?
|
| Culture Media | 1 | 2018 | 898 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 2909 | 0.130 |
Why?
|
| RNA Interference | 4 | 2018 | 2832 | 0.120 |
Why?
|
| ARNTL Transcription Factors | 1 | 2015 | 97 | 0.120 |
Why?
|
| Fructose-Bisphosphatase | 1 | 2014 | 25 | 0.120 |
Why?
|
| Depressive Disorder, Major | 3 | 2018 | 4818 | 0.120 |
Why?
|
| Glycolysis | 2 | 2015 | 837 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 627 | 0.110 |
Why?
|
| Lung Neoplasms | 6 | 2014 | 13586 | 0.110 |
Why?
|
| Circadian Rhythm | 2 | 2023 | 2593 | 0.110 |
Why?
|
| RNA, Small Interfering | 3 | 2018 | 3428 | 0.110 |
Why?
|
| Glutamine | 2 | 2015 | 577 | 0.110 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2012 | 86 | 0.100 |
Why?
|
| Neoplasms | 5 | 2023 | 22371 | 0.090 |
Why?
|
| Neoplasm Metastasis | 2 | 2014 | 4912 | 0.090 |
Why?
|
| Genes, Retinoblastoma | 1 | 2011 | 125 | 0.090 |
Why?
|
| Tumor Escape | 1 | 2014 | 372 | 0.090 |
Why?
|
| Cell Cycle Proteins | 3 | 2018 | 3445 | 0.090 |
Why?
|
| Benzoquinones | 1 | 2011 | 198 | 0.090 |
Why?
|
| Animals | 15 | 2024 | 169246 | 0.090 |
Why?
|
| Neuroendocrine Cells | 1 | 2011 | 61 | 0.090 |
Why?
|
| CDC2 Protein Kinase | 1 | 2011 | 212 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2014 | 1406 | 0.090 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2011 | 169 | 0.090 |
Why?
|
| Signal Transduction | 4 | 2019 | 23645 | 0.080 |
Why?
|
| Telomerase | 1 | 2015 | 751 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 1494 | 0.080 |
Why?
|
| Lactams, Macrocyclic | 1 | 2011 | 319 | 0.080 |
Why?
|
| Benzimidazoles | 2 | 2012 | 864 | 0.080 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2012 | 640 | 0.080 |
Why?
|
| Receptor, erbB-3 | 1 | 2010 | 142 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2015 | 2846 | 0.080 |
Why?
|
| Taxoids | 1 | 2012 | 667 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 1120 | 0.080 |
Why?
|
| Catalytic Domain | 1 | 2010 | 699 | 0.070 |
Why?
|
| Pharmacogenetics | 1 | 2012 | 683 | 0.070 |
Why?
|
| Mutation | 3 | 2014 | 30238 | 0.070 |
Why?
|
| Apoptosis | 2 | 2014 | 9523 | 0.070 |
Why?
|
| Carrier Proteins | 2 | 2018 | 4937 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2012 | 2954 | 0.070 |
Why?
|
| Glucose | 2 | 2015 | 4352 | 0.070 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2011 | 454 | 0.070 |
Why?
|
| Sequence Alignment | 1 | 2010 | 2179 | 0.060 |
Why?
|
| Mice | 11 | 2018 | 82029 | 0.060 |
Why?
|
| BRCA1 Protein | 1 | 2011 | 1155 | 0.060 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2014 | 596 | 0.060 |
Why?
|
| Cell Movement | 2 | 2014 | 5210 | 0.060 |
Why?
|
| Sirolimus | 1 | 2011 | 1540 | 0.060 |
Why?
|
| Neuroblastoma | 1 | 2012 | 1266 | 0.060 |
Why?
|
| Models, Molecular | 2 | 2014 | 5403 | 0.060 |
Why?
|
| Homeostasis | 1 | 2015 | 3348 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2018 | 10266 | 0.050 |
Why?
|
| Humans | 19 | 2024 | 768166 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2018 | 19015 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2014 | 5703 | 0.050 |
Why?
|
| Cell Line, Tumor | 6 | 2015 | 17140 | 0.050 |
Why?
|
| Mice, Nude | 3 | 2014 | 3623 | 0.050 |
Why?
|
| Cytokines | 1 | 2016 | 7453 | 0.050 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2012 | 1767 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 18349 | 0.040 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2014 | 3187 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2014 | 5432 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 13421 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 4058 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2014 | 1151 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2010 | 4214 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 4282 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 17622 | 0.040 |
Why?
|
| Gene Expression | 1 | 2010 | 7598 | 0.040 |
Why?
|
| Amino Acids | 1 | 2023 | 1716 | 0.030 |
Why?
|
| Inflammation | 1 | 2016 | 10873 | 0.030 |
Why?
|
| Proteomics | 1 | 2010 | 3912 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2015 | 33 | 0.030 |
Why?
|
| Cell Line | 2 | 2023 | 15597 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2014 | 6124 | 0.030 |
Why?
|
| Period Circadian Proteins | 1 | 2015 | 97 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2012 | 4528 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2015 | 193 | 0.030 |
Why?
|
| Keratin-15 | 1 | 2014 | 22 | 0.030 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2014 | 48 | 0.030 |
Why?
|
| Keratin-5 | 1 | 2014 | 43 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2015 | 10474 | 0.030 |
Why?
|
| Genomics | 1 | 2010 | 5926 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2014 | 12168 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2023 | 3655 | 0.030 |
Why?
|
| Metabolomics | 1 | 2023 | 1674 | 0.030 |
Why?
|
| Dimerization | 1 | 2015 | 887 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 11878 | 0.030 |
Why?
|
| NADP | 1 | 2014 | 229 | 0.030 |
Why?
|
| Aminooxyacetic Acid | 1 | 2012 | 7 | 0.030 |
Why?
|
| Repressor Proteins | 2 | 2015 | 2982 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 2014 | 297 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9263 | 0.030 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2014 | 286 | 0.030 |
Why?
|
| bcl-X Protein | 1 | 2014 | 412 | 0.030 |
Why?
|
| Brain | 1 | 2019 | 27360 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2015 | 8647 | 0.020 |
Why?
|
| Acyltransferases | 1 | 2014 | 306 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2010 | 3611 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2012 | 281 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2015 | 1524 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 801 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 859 | 0.020 |
Why?
|
| eIF-2 Kinase | 1 | 2011 | 147 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 611 | 0.020 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2010 | 93 | 0.020 |
Why?
|
| Focal Adhesions | 1 | 2010 | 113 | 0.020 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2010 | 183 | 0.020 |
Why?
|
| Leukocytes | 1 | 2018 | 2035 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2011 | 8317 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2012 | 714 | 0.020 |
Why?
|
| Caspases | 1 | 2012 | 882 | 0.020 |
Why?
|
| Indazoles | 1 | 2011 | 306 | 0.020 |
Why?
|
| Mitochondria | 2 | 2014 | 3681 | 0.020 |
Why?
|
| Neuregulin-1 | 1 | 2010 | 136 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 1750 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1606 | 0.020 |
Why?
|
| Cell Transdifferentiation | 1 | 2010 | 186 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 637 | 0.020 |
Why?
|
| Glutathione | 1 | 2011 | 589 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2011 | 423 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2010 | 331 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 13676 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 1143 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 812 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 1625 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2010 | 539 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 2014 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 3772 | 0.020 |
Why?
|
| CHO Cells | 1 | 2010 | 1379 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2015 | 2932 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 2474 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 1754 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2011 | 1497 | 0.020 |
Why?
|
| Metabolome | 1 | 2014 | 1009 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 1338 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 6020 | 0.020 |
Why?
|
| Epithelium | 1 | 2011 | 1607 | 0.020 |
Why?
|
| Cricetinae | 1 | 2010 | 2423 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2011 | 1230 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 1679 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 1133 | 0.020 |
Why?
|
| Lung | 2 | 2014 | 10099 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2014 | 2323 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2014 | 2211 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 2885 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2014 | 2857 | 0.010 |
Why?
|
| Base Sequence | 1 | 2015 | 12421 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2015 | 2907 | 0.010 |
Why?
|
| Swine | 1 | 2014 | 5995 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 5797 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 21206 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2011 | 5027 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 6231 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3096 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 2149 | 0.010 |
Why?
|
| Quinazolines | 1 | 2010 | 1373 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 5505 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 2055 | 0.010 |
Why?
|
| Indoles | 1 | 2011 | 1836 | 0.010 |
Why?
|
| Ligands | 1 | 2010 | 3284 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 1890 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2014 | 3703 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 6082 | 0.010 |
Why?
|
| Neutrophils | 1 | 2014 | 3786 | 0.010 |
Why?
|
| DNA Damage | 1 | 2011 | 2469 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2010 | 4146 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2010 | 2433 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4793 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2015 | 12800 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2011 | 3139 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 7608 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 6316 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2892 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 2830 | 0.010 |
Why?
|
| Aged | 3 | 2018 | 171504 | 0.010 |
Why?
|
| Macrophages | 1 | 2014 | 5799 | 0.010 |
Why?
|
| Young Adult | 2 | 2016 | 60066 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 9561 | 0.010 |
Why?
|
| Female | 5 | 2018 | 397192 | 0.010 |
Why?
|
| Depression | 1 | 2018 | 8230 | 0.010 |
Why?
|
| Middle Aged | 3 | 2018 | 223492 | 0.010 |
Why?
|
| Adult | 3 | 2018 | 223646 | 0.010 |
Why?
|
| Adolescent | 2 | 2016 | 89169 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2014 | 7876 | 0.010 |
Why?
|
| Male | 4 | 2018 | 364719 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 13671 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5804 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6669 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 10399 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9538 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 9615 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 20227 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2018 | 54926 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 20760 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2012 | 65371 | 0.000 |
Why?
|